Cost-effectiveness of child caries management: results from the FiCTION RCT by Homer, T et al.
This is a repository copy of Cost-effectiveness of child caries management: results from 
the FiCTION RCT.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/149438/
Version: Accepted Version
Article:
Homer, T, Maguire, A, Douglas, GVA orcid.org/0000-0002-0531-3909 et al. (7 more 
authors) (Accepted: 2020) Cost-effectiveness of child caries management: results from the
FiCTION RCT. Journal of Dental Research. ISSN 0022-0345 (In Press) 
This is an author produced version of a paper accepted for publication in Journal of Dental 
Research. Reprinted by permission of SAGE Publications. 
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Cost-effectiveness of child caries management: a randomised controlled1
trial (FiCTION trial)2
Tara Homer
1*
, Anne Maguire
2
, Gail VA Douglas
3
, Nicola P Innes
4
, Jan E Clarkson
5
, Nina3
Wilson
1
, Vicky Ryan
1
, Elaine McColl
1
, Mark Robertson
4
and Luke Vale
1
.4
5
1
Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK6
2
School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, Newcastle7
upon Tyne, UK8
3
Dental School, University of Leeds, Leeds, UK9
4
School of Dentistry, University of Dundee, Dundee, UK10
5
Dental Health Services Research Unit, University of Dundee, Dundee, UK11
12
*Corresponding Author: Tara Homer13
Population Health Sciences Institute, Newcastle University,14
Newcastle upon Tyne, NE2 4AX, UK15
Email: tara.homer@newcastle.ac.uk16
17
18
19
20
21
22
23
24
25
2Abstract1
Background: A three-arm parallel group, randomised controlled trial set in general dental2
practices in England, Scotland, and Wales was undertaken to evaluate three strategies to3
manage dental caries in primary teeth. Children, with at least one primary molar with caries4
into dentine, were randomised to receive Conventional with best practice prevention (C+P),5
Biological with best practice prevention (B+P), or best practice Prevention Alone (PA).6
Methods: Data on costs were collected via case report forms completed by clinical staff at7
every visit. The co-primary outcomes were incidence of, and number of episodes of, dental8
pain and/or infection avoided. The three strategies were ranked in order of mean cost and a9
more costly strategy was compared with a less costly strategy in terms of incremental cost-10
effectiveness. Costs and outcomes were discounted at 3.5%.11
Results: A total of 1144 children were randomised with data on 1058 children (C+P n=352,12
B+P n=352, PA n=354) used in the analysis. On average, it costs £230 to manage dental13
caries in primary teeth over a period of up to 36 months. Managing children in PA was, on14
average, £19 (97.5% CI: -£18 to £55) less costly than managing those in B+P. In terms of15
effectiveness, on average, there were fewer incidences of, (-0.06; 97.5% CI: -0.14 to 0.02)16
and fewer episodes of dental pain and/or infection (-0.14; 97.5% CI: -0.29 to 0.71) in B+P17
compared to PA. C+P was unlikely to be considered cost-effective, as it was more costly and18
less effective than B+P. Conclusions: The mean cost of a child avoiding any dental pain19
and/or infection (incidence) was £330 and the mean cost per episode of dental pain and/or20
infection avoided was £130. At these thresholds B+P has the highest probability of being21
considered cost-effective. Over the willingness to pay thresholds considered, the probability22
of B+P being considered cost-effective never exceeded 75%.23
3Trial registration: The trial was prospectively registered with the ISRCTN (reference1
number ISRCTN77044005) on the 26
th
January 2009 and East of Scotland Research Ethics2
Committee provided ethical approved (REC reference: 12/ES/0047).3
Keywords: Economic evaluation, caries, caries treatment, clinical studies/trials, pediatric4
dentistry, dental public health5
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4Background1
Dental caries has a large health and economic impact for the United Kingdom (UK) as it is the2
most common disease in children (1-4). Treating oral disease is expensive, costing NHS3
England £3.4 billion annually (5).4
In the UK there is uncertainty surrounding the best strategy to manage caries in primary teeth,5
especially in primary care. There is debate about the clinical- and cost-effectiveness of6
conventional restorations (removing a carious lesion with a drill and placement of a7
restoration) compared to minimally-invasive biologically-orientated strategies (sealing-in a8
carious lesion with an adhesive restoration or preformed metal crown rather than removing9
it), or prevention-focused strategies (6-9).10
Cost-effectiveness analysis allows treatment comparisons in terms of both costs and effects11
(10). Recent cost-effectiveness analyses of managing dental caries found the Hall Technique12
(HT), a method for managing carious lesions by sealing-in, to be cost-effective compared to13
conventional restorations (11) and compared to both conventional restorations and a Non-14
Restorative Cavity Control approach (12). However, these studies followed outcomes on15
single teeth and have focused on one type of biological approach (i.e. HT).16
A large trial, FiCTION (Filling Children's Teeth: Indicated or Not?), was undertaken to17
measure the costs and effects, in terms of dental pain and/or infection, of three strategies to18
manage dental caries in the primary teeth of young children with dentine caries in the UK19
(13). The strategies evaluated were Conventional restorations with best practice prevention20
(C+P), Biological management of carious lesions with best practice prevention (B+P), and21
best practice Prevention Alone (PA). The C+P strategy involved the complete mechanical22
removal of carious tooth tissue using local anesthesia and a drill followed by placement of a23
restoration alongside best practice preventive therapy and has been considered standard24
5practice in the management of dental caries (14, 15). The B+P strategy involved sealing-in1
carious lesions using a variety of techniques including adhesive restorative materials or2
preformed metal crowns placed using the HT along with preventive therapy; Schwendicke et3
al.’s (2018, 2019) analyses focused on the HT component of B+P (11, 12). PA involved4
avoiding restorative intervention and using four components of preventive management;5
toothbrushing (with toothpaste of at least 1000ppmF concentration), dietary advice, fluoride6
varnish application, and fissure sealants to prevent further carious lesions.7
The trial methodology and clinical outcomes are presented elsewhere (13, 16, 17). In brief,8
this multi-center, three-arm, parallel group, patient-randomised controlled trial set in general9
dental practices in England, Scotland, and Wales was undertaken to evaluate three strategies10
to manage caries in the primary teeth of children aged 3 to 7 years with at least one primary11
molar tooth with caries lesions extending into dentine. The original planned follow-up was 312
years but due to an extension in the recruitment period this was revised to an average target13
follow-up of 35.5 months (a minimum of 23 months and a maximum of 36 months).14
Methods15
Reporting for this study follows the Consolidated Health Economic Evaluation Reporting16
Standards (CHEERS) (18). The trial was registered with the ISRCTN (reference number17
ISRCTN77044005) and East of Scotland Research Ethics Committee provided ethical18
approved (REC reference: 12/ES/0047).19
Data Analyses20
The economic evaluation was undertaken from the perspective of the healthcare provider in21
the UK, the National Health Service (NHS).22
Estimation of costs23
6Time/materials-based costing was used to estimate the costs at every visit to manage dental1
caries in primary teeth. These costs depended on the quantity of dental care resources used2
for each child during their time in the trial (up to 36 months post-randomisation). Resource3
use data, to inform the cost analysis, were collected via case report forms (CRFs) completed4
by the clinician at every visit. Costs were categorised as staffing, preventive treatments,5
operative treatments (restoration materials), other associated items (e.g. radiographs),6
referrals, and prescriptions. Capital costs were excluded as all three strategies were provided7
as part of current care; therefore, these costs would have been incurred regardless of which8
strategy was implemented. Unit costs, based on the materials required for each treatment,9
were multiplied by the number of resources used. Unit costs are detailed in Additional File 110
and briefly described below. All costs are in 2018 pounds Sterling.11
The length of time for each visit, based on the start and end time recorded in the CRF, was12
used to estimate dental personnel costs. Time spent providing prevention was subtracted from13
total visit time to take into account that the same personnel may not provide preventive and14
operative treatments. We assumed a dental nurse would be present for the full duration of15
each visit.16
Preventive care was integral to all three arms and was expected to be provided regardless of17
randomised allocation. Preventive treatment costs were the resources used for fluoride18
applications and fissure sealants placed on first permanent molars.19
Operative treatments were included in two arms; C+P (e.g. local anesthetic, carious tissue20
removal, and restoration) and B+P (e.g. partial/no carious tissue removal and restoration), but21
some treatments were included in all three arms (e.g. extractions under local anesthetic and22
pulp therapy). Information on the number of surfaces treated was also collected since23
treatment of more than one tooth surface could incur additional costs (e.g. additional24
7restorative material). The cost of resources used at every visit were also included, regardless1
of treatment. Other treatment costs included radiographs and inhalation sedation.2
A patient referral was reported if a child was referred to a dental hospital/clinic for a3
consultation and/or operative treatment. The costs associated with referrals were categorised4
A-F (see Additional File 2) depending on treatment provided, where it took place, who5
provided it, and the number of visits required.6
Estimation of effects7
The original primary outcome, incidence of dental pain and/or infection was modified during8
the trial to include a co-primary outcome, number of episodes of dental pain and/or infection.9
Number of episodes was included as it was considered more clinically relevant and10
statistically more sensitive to analyse the frequency of dental pain and/or infection11
experienced by a child.12
Incidence is defined as the proportion of children with at least one episode of dental pain and/13
or infection during their time in the study. Episodes were defined on a tooth-by-tooth basis14
based on the frequency of dental pain and/or infection reported during the child’s follow-up.15
However, if multiple teeth had dental pain and/or infection at the same visit, this was counted16
as one episode or if the same tooth had dental pain and/ or infection at consecutive visits, this17
was counted as one episode regardless of the time between visits (13). Data on dental pain18
due to dental caries and clinically diagnosed infection were collected on the CRF at every19
visit. It was assumed that those who did not have regular appointments did not need further20
treatment and/or did not experience dental pain and/or infection.21
Cost-effectiveness analysis22
The economic analysis was conducted on the basis of intention-to-treat (ITT). Children were23
included in the ITT analysis if they had at least one CRF and therefore at least one clinical24
8assessment of the primary outcome. The economic analysis compared the three strategies in1
terms of mean costs and effects over the follow-up period. Both costs and effects were2
discounted at the recommended rate of 3.5% (19). Effects were discounted, based on when3
the incidence or episode of dental pain and/or infection began. To enable the estimation of4
budget impact (20) the average total costs by cost category presented in Table 1 were not5
discounted.6
For the incremental analysis, the strategies were ranked in terms of increasing mean cost and7
a more costly strategy was compared with a less costly strategy in terms of incremental cost-8
effectiveness. A treatment was considered to be dominated if it was more costly and less9
effective than its comparator (10). If a treatment was not dominated, an incremental cost-10
effectiveness ratio (ICER) was estimated. The ICER is the difference in mean costs divided11
by the difference in mean effects and gives an estimate of the mean cost per additional unit of12
effect (10).13
STATA software was used for all analyses (21). Regressions on costs and effects were run14
simultaneously using seemingly unrelated regression (SUR) (22). SUR permits the15
simultaneous estimation of costs and effects, calculated at an individual level, while16
accounting for unobserved individual characteristics that could affect both costs and effects17
and lead to potential correlation between these two dependent variables (23). In addition, the18
SUR controlled for additional covariates (age, time in study, and practice variation) that may19
affect costs, effects, or both.20
A stochastic sensitivity analysis, using the bootstrapping technique (24), explored the impact21
of the statistical imprecision surrounding estimates of costs, effects, and cost-effectiveness.22
The bootstrapped results from the incremental analysis were used to estimate net benefits23
(NB). The NB statistic is given by:24
91% ȜîǻH±ǻF1
ZKHUH Ȝ LV WKH ZLOOLQJQHVV WR SD\ WKUHVKROG ǻ LV WKH GLIIHUHQFH EHWZHHQ D VWUDWHJ\ DQG LWV2
comparator (i.e. least costly strategy), e are the mean effects, and c are the mean costs (10). A3
strategy is considered to be cost-effective if NB > 0 or, when more than two strategies are4
compared, a strategy which has the highest NB at a given threshold value for society’s5
willingness to pay for a unit of oral health benefit. As there is no nationally or internationally6
agreed willingness to pay threshold to avoid dental pain and/or infection an arbitrary7
threshold of £1000, used by O’Neill et al. (2017), was adopted for this analysis (25). A cost-8
effectiveness frontier (26) was generated to illustrate uncertainty by showing which strategy9
was likely to have the highest NB over a range of different willingness to pay values.10
Results11
A total of 1144 children were randomised and data on 1058 children were used in the12
economic analysis (n=86 children did not have any clinical assessment of the primary13
outcome and were not included in the ITT analysis). The children included in the economic14
analysis were evenly distributed across the three arms in terms of numbers randomised and15
baseline characteristics; 352 randomised to B+P, 352 to C+P, and 354 to PA. On average,16
children were 6 years old [sd: 1.3] when recruited and there was an even split between17
females (51%) and males (49%). The CONSORT (Consolidated Standards of Reporting18
Trial) flow diagram is provided in Additional File 6 but additional baseline characteristics,19
and clinical findings are presented elsewhere (13). The median follow-up was 33.8 months20
(IQR 23.8, 36.7).21
The percentage of missing data for the economic analysis was low (<5%). There were 771322
visits recorded across the three arms. On average, children had seven visits during their time23
in the trial, each lasting 21 minutes. All three strategies were similar in terms of average24
10
number of visits (mean visits [sd]: C+P 7.7 [4.2], B+P 7.4 [4.1], and PA 6.8 [3.7]) and1
duration of visits (mean minutes [sd]: C+P 21.8 [6.9], B+P 21.2 [7.2], and PA 20.1 [6.7]).2
The number of visits at which preventive treatment was provided was similar across the three3
arms with slightly more prevention provided in the PA arm (C+P 79%, B+P 79%, and PA4
85% of visits). The three strategies differed in the frequency of operative treatments5
provided, with less than 20% of all PA visits involving operative treatment compared to over6
40% of B+P and C+P visits. The type of operative treatment provided also differed, as would7
be expected given the nature of the different strategies.8
A total of 96 children (C+P n=31, B+P n=31, and PA n=34 children) were referred on 1079
occasions for additional consultations and/or further treatment (C+P n=32, B+P n=36, and10
PA n=39 referrals) resulting in 52 general anesthetics (GA) being undertaken (C+P n=15,11
B+P n=12, PA n=25 referrals with GA). Four children did not attend their referral12
appointment (n=1 C+P, n=3 PA).13
Table 1 summarizes the average cost per child per visit for the three strategies.14
Table 1 Average total cost (£) per child by strategy
a
15
Total cost per child (£)
C+P B+P PA
Resource Mean [SD] Mean [SD] Mean [SD]
Staff costs 18.78 [6.07] 18.28 [6.27] 17.36 [5.95]
Prevention costs 0.66 [0.76] 0.78 [0.88] 0.81 [0.88]
Operative treatment costs 8.18 [6.72] 7.84 [5.96] 4.09 [4.05]
11
Other treatments costs 0.66 [2.56] 0.47 [1.84] 0.52 [1.90]
Referral costs 5.22 [23.35] 4.96 [23.65] 10.23 [43.81]
Prescription costs 0.07 [0.29] 0.04 [0.14] 0.08 [0.32]
Total practice level treatment
cost (exc. referrals) per child
per visit
28.36 [11.08] 27.40 [10.81] 22.86 [8.11]
Total treatment cost per child 250.48 (221.70) 231.27 (214.47) 211.32 (257.28)
a
costs are not discounted in this table but presented in the common price year to allow for budget impact1
2
On average, it cost £230 to manage dental caries in a young child with at least one primary3
tooth with a dentinal carious lesion over a period of up to 36 months. On average, C+P was4
the most costly and PA was the least costly strategy. Staff time, operative treatments, and5
patient referrals were the main cost drivers. As expected, C+P and B+P incurred more6
operative treatment costs compared to PA.7
As PA was, on average, the least costly strategy we compared this to B+P, the next costly8
strategy, and lastly C+P was included in the comparison. In terms of effectiveness, there was9
no evidence of a difference in incidence, or in episodes, of dental pain and/or infection10
between the three strategies. Table 2 summaries the results of the incremental analysis.11
12
13
14
12
1
Table 2 Cost-effectiveness analysis for the comparison of PA vs B+P vs C+P
a
2
Investigation
strategy
Cost [£]
[97.5% CI]
b
Incremental
cost [£]
[97.5% CI]
b c
Incidence
[97.5% CI]
b
Incremental
incidence
[97.5% CI]
b c
ICER
c
[£]
Incremental cost per incidence of dental pain and/or infection avoided
PA (n=354) 206
[176 to 237]
0.44
[0.39 to 0.50]
B+P (n=352) 226
[201 to 252]
19
[-18 to 55]
0.39
[0.33 to 0.45]
-0.058
[-0.14 to 0.02]
328
C+P (n=352) 245
[219 to 271]
0.41
[0.35 to 0.47]
Dominated
by B+P
Incremental cost per episode of dental pain and/or infection avoided
Investigation
strategy
Cost [£]
[97.5% CI]
b
Incremental
cost [£]
[97.5% CI]
b c
Episodes
[97.5% CI]
b
Incremental
episodes
[97.5% CI]
b c
ICER
c
[£]
PA (n=354) 206
[176 to 237]
0.70
[0.58 to 0.82]
B+P (n=352) 226
[201 to 252]
19
[-18 to 55]
0.56
[0.46 to 0.67]
-0.143
[-0.29 to 0.01]
133
C+P (n=352) 245
[219 to 271]
0.60
[0.49 to 0.71]
Dominated
by B+P
a
costs and effects are discounted at 3.5%;
b
97.5% CI was used as it adjusts for multiple comparisons and3
should be interpreted as if it were a 95% CI;
c
estimated based on adjusted analysis (n=1057; n=1 child missing4
information on age);
d
ICER = incremental cost-effectiveness ratio5
13
1
B+P was, on average, more costly but more effective, in terms of both incidence of, and2
episodes of, dental pain and/or infection avoided, compared to PA. At a willingness to pay3
threshold of £330 we would consider B+P cost-effective to avoid an incidence and £130 to4
avoid an episode of dental pain and/or infection compared to PA. As C+P was, on average,5
more costly and less effective than B+P, in terms of both incidence of, and episodes of, dental6
pain and/or infection, it was dominated by B+P.7
Figure 1 illustrates uncertainty surrounding the point estimates in Table 2. The figure presents8
the strategy with the highest probability of being considered cost-effective at each willingness9
to pay threshold to avoid an incidence of dental pain and/or infection.10
Figure 1 illustrates that PA would have the highest probability (87%) of being considered11
cost-effective if a decision were to be based on cost alone. However, as the willingness to pay12
threshold increases, the probability of B+P being considered cost-effective increases, but it13
never exceeds 65%. C+P would not be considered cost-effective compared to PA and B+P in14
this analysis.15
Figure 2 illustrates the strategy with the highest probability of being considered cost-effective16
at the different willingness to pay thresholds to avoid an episode of dental pain and/or17
infection.18
In terms of episodes of dental pain and/or infection, the conclusions are similar except that19
B+P would be considered cost-effective at a lower willingness to pay threshold. The20
probability of B+P being considered cost-effective never exceeds 75%.21
Discussion22
14
On average, it costs £230 to manage dental caries in primary teeth in a child with at least one1
tooth with a dentinal caries lesion over a period of up to 36 months. The main cost drivers2
were staff time, operative treatments, and patient referrals. On average, PA incurred a higher3
referral cost because that arm had more referrals and more referrals requiring GA, an4
important consideration in view of the morbidity associated with GA use (27-29).5
Although in terms of cost-effectiveness PA was, on average, the least costly treatment, it was6
also the least effective for both incidence of, and episodes of, dental pain and/or infection.7
There was an 87% probability that PA would be considered cost-effective as the least costly8
option but B+P and C+P would, on average, provide more oral health benefits, albeit at a9
higher cost. If society was willing to pay £330 to avoid one additional child experiencing10
dental pain and/or infection, B+P would have the highest probability (47%) of being11
considered cost-effective compared to PA (46%) and C+P (7%). Similarly, when society is12
willing to pay £130 or more to avoid an episode of dental pain and/or infection, B+P would13
have the highest probability (49%) of being considered cost-effective compared to PA (45%)14
and C+P (6%).15
Vermaire et al. (2014) and Samnaliev et al. (2015) came to similar conclusions in their16
analyses, in that treatments aimed at caries prevention increased the cost of providing17
treatment and that the opportunity cost of these treatments is dependent on the payers’18
willingness-to-pay (30, 31). Our results differ from other studies in which the HT, which was19
a component of our B+P intervention, was reported to be more effective and less costly (11,20
12) when compared to conventional and preventive based strategies. However, both of these21
studies by Schwendicke et al. (2018, 2019) were based on treating a single tooth, or two22
contralateral teeth per child whereas in our study the whole child/mouth (up to 20 primary23
teeth per child) could be treated, a situation more representative of real life treatment24
provision (11, 12). Our study also had considerably more data available to inform our25
15
analysis (n=1058 children, n=2721 teeth; compared with n=142 children and teeth in1
Schwendicke et al. 2018; and n=91 children, n=182 teeth in Schwendicke et al. 2019) (11,2
12). The costs estimated in the two Schwendicke et al. (2018, 2019) studies were based on3
current charges to the health system (11, 12). In the present analysis we based our costs on a4
very detailed costing exercise, however, when we used current charges to the NHS in a5
sensitivity analysis we still reached the same conclusion (see Additional Files 3, 4, and 5).6
Schwendicke et al. (2019) found a negligible difference in total treatment costs between HT7
and conventional treatment and this difference only became clinically and statistically8
significant when patient costs were considered (11). Parental time and travel costs to attend9
appointments were not considered in our analysis. Inclusion of such costs are unlikely to10
change our conclusions as the average number of visits and length of visits were similar11
across the arms. Costs incurred by the parent and child due to toothache, such as time off12
work, childcare, and time off school, were considered in a sensitivity analysis but did not13
change our overall conclusions. In terms of oral health effects, direct comparisons could not14
be made with previous studies (11, 12) which considered the pain associated with dental15
caries together with endodontic treatment and extractions. The main differences in our study16
are, firstly, that B+P encompassed a number of minimally-invasive restorations of which the17
HT was only one and secondly, treatment was at the participant level (including all primary18
teeth) and not at the single tooth level.19
This economic analysis had a number of strengths and limitations. The main strength was that20
the analysis was pre-planned and the data used were collected as part of the trial. There were21
few missing data and all available data were included in the analysis despite the varying22
follow-up. A limitation of the analysis was that SUR model may not have been an23
appropriate fit for the co-primary outcomes. However, a trade-off was made between fitting24
the most appropriate model and applying one that allows for the correlation of costs and25
16
outcomes, which the SUR approach does. Finally, capital costs were excluded from the1
analysis; this omission reduced the total cost of each arm equally hence the incremental costs,2
ICER, and our overall conclusions remain unchanged.3
In practical terms, we do not know society’s willingness to pay threshold to avoid dental pain4
and/or infection in a primary tooth. A judgement is required as to what value the NHS places5
on avoiding dental pain and/or infection. Recent research conducted by Lord et al. (2015)6
estimated the willingness to pay to avoid dental caries with pain in a primary tooth (32). They7
estimated this to be £153 (95% CI: £93 to £213 – inflated to 2017) (33). If we adopted this as8
the willingness to pay threshold the PA arm would have a 68% probability of being9
considered cost-effective compared to B+P (29%) and C+P (3%) in terms of an incidence of10
dental pain and/or infection avoided. A willingness to pay threshold to avoid an episode of11
dental pain and/or infection also needs to be determined but based on the Lord et al. (2015)12
threshold, B+P would have the highest probability (53%) of being considered cost-effective13
compared to PA (40%) and C+P (7%). Further research is needed to identify the most14
appropriate threshold to assess our results.15
Conclusions16
To conclude, on average, PA is the least costly, despite having more referrals requiring GA,17
but the least effective strategy for managing dental caries in primary teeth. B+P has the18
potential to provide more oral health benefits to children with dentinal carious lesion in at19
least one primary molar tooth, however this comes at an additional cost. Over the willingness20
to pay values considered, the probability of B+P being considered cost-effective was21
approximately no higher than 65% to avoid an incidence of dental pain and/or infection and22
no higher than 75% to avoid an episode of dental pain and/or infection. It is unlikely that C+P23
would be considered cost-effective.24
25
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Additional file 3.doc. “Cost-effectiveness analysis for the comparison of PA vs B+P vs C+P16
arms based on fee-for-service costs in Scotland only (n=287)” is a the results of a sensitivity17
analysis which estimates costs based on charges to the NHS, based on the Scottish18
reimbursement rates (fee-for-service).19
Additional file 4.doc. “Cost-effectiveness analysis for the comparison of PA vs B+P vs C+P20
arms based on units of dental activity in England and Wales only costs (n=771)” is a the21
results of a sensitivity analysis which estimates costs based on charges to the NHS, based on22
the English reimbursement rates (Units of Dental Activity).23
25
Additional file 5.doc. “Cost-effectiveness analysis for the comparison of PA vs B+P vs C+P1
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(n=1058)” is a the results of a sensitivity analysis which estimates costs based on charges to3
the NHS, based on the both the Scottish and English reimbursement rates.4
Additional file 6.jpeg “CONSORT flow diagram of participant journey through trial”5
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